Suchergebnisse - "Urbina, Tomas"

PubPharm (8)

1

Corticosteroids induce an early but limited decrease in IL-6 dependent pro-inflammatory responses in critically ill COVID-19 patients

enthalten in: Minerva anestesiologica | 2024

von Urbina, T. | Gabarre, P. | Bonny, V. | +15

2

Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients : a prospective multicenter observational study

enthalten in: Critical care (London, England) | 2024

von Petit, M. | Bidar, F. | Fosse, Q. | +19

3

Epidemiology and Clinical Patterns of Lung Abscesses in ICU : A French Multicenter Retrospective Study

enthalten in: Chest | 2024

von Montméat, V. | Bonny, V. | Urbina, T. | +11

4

High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone : A Multicenter Cohort Study

enthalten in: Critical care medicine | 2023

von Lopinto, J. | Arrestier, R. | Peiffer, B. | +15

CommentIn: Crit Care Med. 2023 Oct 1;51(10):1434-1436. - PMID 37707381

5

Skin biopsy in adult patients with meningococcal purpura fulminans : a multicenter retrospective cohort study

enthalten in: Critical care (London, England) | 2023

von Contou, D. | Béduneau, G. | Rabault, C. | +50

6

Spontaneous pneumomediastinum : a surrogate of P-SILI in critically ill COVID-19 patients

enthalten in: Critical care (London, England) | 2022

von Elabbadi, A. | Urbina, T. | Berti, E. | +8

CommentIn: Crit Care. 2023 Jan 24;27(1):38. - PMID 36694214

7

SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients : A Prospective Multicenter Cohort Study

enthalten in: Viruses | 2022

von Fourati, S. | Audureau, E. | Arrestier, R. | +27

8

Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients : A retrospective matched-cohort analysis

enthalten in: Innate immunity | 2022

von Urbina, T. | Lavillegrand, J. | Garnier, M. | +16

1
[1]